SuperworthCitroTech EPS CITR
Diluted earnings per share by quarter and over the last twelve months, from 2020.
- Last 12 months, to Jun 30, 2026
- −$1.44
- Latest quarter, Q2 FY26
- −$0.18
- Fiscal year 2025
- −$3.44
CitroTech's earnings per share was −$1.44 over the twelve months to Jun 30, 2026.
In its latest quarter, Q2 FY26, it was −$0.18.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | −$3.44 | n/a |
| FY2024 | −$0.77 | n/a |
| FY2023 | −$0.54 | n/a |
| FY2022 | −$0.36 | n/a |
| FY2021 | −$0.30 | n/a |
| FY2020 | $0.00 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | −$0.18 | n/a | −$1.44 | |
| Q1 FY26 | −$0.33 | n/a | −$2.40 | |
| Q4 FY25 | −$0.34 | n/a | −$3.44 | |
| Q3 FY25 | −$0.59 | n/a | −$3.40 | |
| Q2 FY25 | −$1.14 | n/a | −$2.92 | |
| Q1 FY25 | −$1.37 | n/a | −$1.90 | |
| Q4 FY24 | −$0.30 | n/a | −$0.77 | |
| Q3 FY24 | −$0.11 | n/a | −$0.47 | |
| Q2 FY24 | −$0.12 | n/a | −$0.90 | |
| Q1 FY24 | −$0.24 | n/a | −$0.78 | |
| Q4 FY23 | $0.00 | n/a | −$0.54 | |
| Q3 FY23 | −$0.54 | n/a | −$0.54 |
Against its peers
Companies in Chemicals nearest CitroTech's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| CITRCitroTech | −$1.44 | |
| FTLFFitlife Brands | $0.62 | −23% a year |
| BTMDbiote | $0.10 | −89% a year |
| NAGENiagen Bioscience | $0.18 | −14% a year |
| Peer median | $0.18 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on CitroTech
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.